# Korsana Biosciences, Inc. (KRSA)

> Source: Nexqual · https://nexqual.com/KRSA · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Korsana Biosciences, Inc. (KRSA), nexqual.com/KRSA" · informational, not investment advice.

**Price:** USD 33.65 (-1.95% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 34.32 · day 33.43–35.15 · 52w 7.19–59.36 · market cap $1.53B · NCM

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (5 analysts), mean target USD 44 (range 8–70).
- Total return with dividends: 1Y +113.7% vs S&P 500 +18.1%; 5Y -91.1% vs S&P 500 +85.1%.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 5 analysts; mean target USD 44 (low 8, high 70).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-05 | Wedbush | Initiated | Outperform | $44 |
| 2026-09-28 | Guggenheim | Initiated | Buy | $70 |
| 2026-09-14 | Stifel | Initiated | Buy | $43 |
| 2026-09-14 | TD Cowen | Initiated | Buy |  |
| 2026-09-11 | UBS | Initiated | Buy | $55 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | +113.7% | -91.1% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +114.2% | -38.2% |
| Volatility (annualized) | 174.8% | 123.3% |
| Max drawdown | -54.7% (Apr 2026→Apr 2026) | -98.1% (Nov 2021→Feb 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/KRSA · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt